SGLT2i in Acute Heart Failure, The Earlier The Better? SGLT2i in Acute Heart Failure, The Earlier The Better?

Ileana Pi ña interviews Zachary Cox, PharmD, about the DICTATE-AHF trial on the initiation of the SGLT2 inhibitor, dapagliflozin, early in acute heart failure decompensation.theheart.org on Medscape

Source: Medscape Cardiology Headlines - September 20, 2023 Category: Cardiology Tags: Cardiology Commentary Source Type: news